Recombinant Human CCNB Protein，His

CCNB, or Cyclin B, is a critical regulatory protein involved in the control of the cell cycle, particularly during the transition from G2 phase to mitosis. Research into CCNB and its associated pathways has gained prominence due to its essential role in cellular proliferation and its implications in cancer biology. The dysregulation of CCNB expression or activity has been linked to various malignancies, making it a target for therapeutic interventions. Moreover, CCNB is known to form complexes with Cyclin-dependent kinases (CDKs), facilitating the phosphorylation of key substrates that drive mitotic entry. Recent studies have focused on the structural and functional characterization of CCNB as a recombinant protein to better understand its interaction with CDKs and other regulatory molecules. This research aims to elucidate the mechanisms by which CCNB contributes to cell cycle progression and to identify potential pharmaceutical targets for cancer treatment. By producing CCNB as a recombinant protein, scientists can perform in vitro assays to study its biochemical properties, interactions, and potential inhibitors, paving the way for novel therapeutic strategies aimed at regulating cell division in cancerous cells. The insights gained from these studies may not only enhance our understanding of cell cycle regulation but also contribute to the development of targeted therapies that can improve patient outcomes in oncological settings.